APA (7th ed.) Citation

Zeng, X., Sheng, X., Wang, P., Xin, H., Guo, Y., Lin, Y., . . . Xie, W. (2021). Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis. Hepatology International, 15(1), 155-165. https://doi.org/10.1007/s12072-020-10117-y

Chicago Style (17th ed.) Citation

Zeng, Xin, et al. "Low-dose Rifaximin Prevents Complications and Improves Survival in Patients with Decompensated Liver Cirrhosis." Hepatology International 15, no. 1 (2021): 155-165. https://doi.org/10.1007/s12072-020-10117-y.

MLA (9th ed.) Citation

Zeng, Xin, et al. "Low-dose Rifaximin Prevents Complications and Improves Survival in Patients with Decompensated Liver Cirrhosis." Hepatology International, vol. 15, no. 1, 2021, pp. 155-165, https://doi.org/10.1007/s12072-020-10117-y.